M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Middle East Pharmaceutical Industries Company SJSC
Total Liabilities & Equity Peer Comparison

Comparables:
2070
J
4015

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Total Liabilities & Equity
ď·Ľ444.9m
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Total Liabilities & Equity
ď·Ľ4.4B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Total Liabilities & Equity
ď·Ľ1.7B
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Total Liabilities & Equity?
Total Liabilities & Equity
444.9m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Total Liabilities & Equity amounts to 444.9m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
6%

Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Middle East Pharmaceutical Industries Company SJSC have been 6% over the past three years .

Back to Top